Brief: Roche Launches The Cobas Mpx-E Assay
March 30 (Reuters) - ROCHE HOLDING AG ROPC.S: ROCHE LAUNCHES THE COBAS MPX-E ASSAY, A NEW 4-IN-1 DONOR SCREENING TEST TO FURTHER SAFEGUARD THE GLOBAL BLOOD SUPPLY ROCHE HOLDING AG - COBAS MPX-E TEST PROVIDES FOUR VIRAL RESULTS IN SINGLE ASSAY ROCHE HOLDING AG - COBAS MPX-E ENABLES FASTER TURNAROUND AND HEV SCREENING WITHOUT EXTRA INSTRUMENTATION Source text: ID:nGNEbBSSNc Further company coverage: ROPC.S (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza